These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2589363)

  • 21. Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections.
    Kljucar S; Heimesaat M; von Pritzbuer E; Timm J; Scholl H; Beermann D
    Am J Med; 1989 Nov; 87(5A):52S-56S. PubMed ID: 2589385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous or sequential ciprofloxacin therapy in hospitalised patients with a broad spectrum of infections: a post-marketing surveillance study.
    Koch H; Landen H; Stauch K
    Clin Drug Investig; 2006; 26(11):645-54. PubMed ID: 17163299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral ciprofloxacin treatment of infections in geriatric patients.
    Yangco BG; Kenyon VS; Halkias KD; Bogel JA; Toney JF; Chmel H
    Clin Ther; 1989; 11(4):503-10. PubMed ID: 2776166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.
    Paladino JA; Sperry HE; Backes JM; Gelber JA; Serrianne DJ; Cumbo TJ; Schentag JJ
    Am J Med; 1991 Nov; 91(5):462-70. PubMed ID: 1951408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous ciprofloxacin for infections in cancer patients.
    Rolston KV; Haron E; Cunningham C; Bodey GP
    Am J Med; 1989 Nov; 87(5A):261S-265S. PubMed ID: 2589375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients.
    Kelsey SM; Wood ME; Shaw E; Newland AC
    Am J Med; 1989 Nov; 87(5A):274S-277S. PubMed ID: 2589377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections.
    Haddow A; Greene S; Heinz G; Wantuck D
    Am J Med; 1989 Nov; 87(5A):113S-115S. PubMed ID: 2686410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
    Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure.
    Gentry LO; Koshdel A
    Am J Med; 1989 Nov; 87(5A):132S-135S. PubMed ID: 2686413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
    Esposito S; Galante D; Bianchi W; Gagliardi R
    Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis.
    van Poppel H; Baert L
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S76-7. PubMed ID: 3325932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciprofloxacin in patients with bacteremic infections. The Spanish Group for the Study of Ciprofloxacin.
    Bouza E; Díaz-López MD; Bernaldo de Quirós JC; Rodríguez-Créixems M
    Am J Med; 1989 Nov; 87(5A):228S-231S. PubMed ID: 2589366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
    Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C
    Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
    Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ
    Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.
    Khan FA; Basir R
    Chest; 1989 Sep; 96(3):528-37. PubMed ID: 2670465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter, phase IV evaluation of intravenous ciprofloxacin as initial therapy in patients with lower respiratory tract, urinary tract, and skin/skin structure infections.
    Pankey GA
    Clin Ther; 1995; 17(3):353-65. PubMed ID: 7585840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative, double-blind study of intravenous ciprofloxacin and intravenous ceftazidime in serious infection.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vazquez CR
    Am J Med; 1989 Nov; 87(5A):195S-197S. PubMed ID: 2686423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.